Ferraiuolo Laura, Meyer Kathrin, Sherwood Thomas W, Vick Jonathan, Likhite Shibi, Frakes Ashley, Miranda Carlos J, Braun Lyndsey, Heath Paul R, Pineda Ricardo, Beattie Christine E, Shaw Pamela J, Askwith Candice C, McTigue Dana, Kaspar Brian K
The Research Institute, Nationwide Children's Hospital, Columbus, OH 43205; Department of Neuroscience, Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield S10 2HQ, United Kingdom.
The Research Institute, Nationwide Children's Hospital, Columbus, OH 43205.
Proc Natl Acad Sci U S A. 2016 Oct 18;113(42):E6496-E6505. doi: 10.1073/pnas.1607496113. Epub 2016 Sep 29.
Oligodendrocytes have recently been implicated in the pathophysiology of amyotrophic lateral sclerosis (ALS). Here we show that, in vitro, mutant superoxide dismutase 1 (SOD1) mouse oligodendrocytes induce WT motor neuron (MN) hyperexcitability and death. Moreover, we efficiently derived human oligodendrocytes from a large number of controls and patients with sporadic and familial ALS, using two different reprogramming methods. All ALS oligodendrocyte lines induced MN death through conditioned medium (CM) and in coculture. CM-mediated MN death was associated with decreased lactate production and release, whereas toxicity in coculture was lactate-independent, demonstrating that MN survival is mediated not only by soluble factors. Remarkably, human SOD1 shRNA treatment resulted in MN rescue in both mouse and human cultures when knockdown was achieved in progenitor cells, whereas it was ineffective in differentiated oligodendrocytes. In fact, early SOD1 knockdown rescued lactate impairment and cell toxicity in all lines tested, with the exclusion of samples carrying chromosome 9 ORF 72 (C9orf72) repeat expansions. These did not respond to SOD1 knockdown nor did they show lactate release impairment. Our data indicate that SOD1 is directly or indirectly involved in ALS oligodendrocyte pathology and suggest that in this cell type, some damage might be irreversible. In addition, we demonstrate that patients with C9ORF72 represent an independent patient group that might not respond to the same treatment.
少突胶质细胞最近被认为与肌萎缩侧索硬化症(ALS)的病理生理过程有关。在此我们表明,在体外,突变型超氧化物歧化酶1(SOD1)小鼠的少突胶质细胞可诱导野生型运动神经元(MN)兴奋性过高并导致其死亡。此外,我们使用两种不同的重编程方法,从大量对照以及散发性和家族性ALS患者中高效地获得了人少突胶质细胞。所有ALS少突胶质细胞系通过条件培养基(CM)以及在共培养中诱导MN死亡。CM介导的MN死亡与乳酸生成和释放减少有关,而共培养中的毒性与乳酸无关,这表明MN的存活不仅由可溶性因子介导。值得注意的是,当在祖细胞中实现敲低时,人SOD1短发夹RNA(shRNA)处理可在小鼠和人类培养物中挽救MN,而在分化的少突胶质细胞中则无效。事实上,早期SOD1敲低挽救了所有测试细胞系中的乳酸损伤和细胞毒性,但携带9号染色体开放阅读框72(C9orf72)重复扩增的样本除外。这些样本对SOD1敲低无反应,也未表现出乳酸释放损伤。我们的数据表明,SOD1直接或间接参与了ALS少突胶质细胞病变,并提示在这种细胞类型中,一些损伤可能是不可逆的。此外,我们证明携带C9ORF72的患者代表了一个独立的患者群体,可能对相同的治疗无反应。